All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after ...

Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...

Days after proposing to settle a data breach lawsuit for $30 million, 18-year-old genetic testing company 23andMe now faces ...

Nearly the entire board of directors for 23andMe has resigned — a move that apparently was news to its overly-optimistic ...

We, the independent directors of the 23andMe Board, hereby tender our resignations, effective immediately.

New York, New York--(Newsfile Corp. - September 22, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ: ME) regarding whether ...

The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.

Ann Wojcicki, CEO and co-founder of 23andMe, says she is still planning to take the genetic-testing company private despite ...

In a letter to CEO Anne Wojcicki, the directors said they’d resign “rather than have a protracted and distracting difference of view with you” about the company’s future.

(The Hill) — All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave ...

All seven independent directors of DNA-testing company 23andMe ME-0.29%decrease; red down pointing triangle resigned Tuesday, following a protracted negotiation with founder and Chief Executive ...